Objectives To describe the global trends of pulmonary nontuberculous mycobacteria (NTM)
infection and disease. Methods A systematic review of studies including culture-based NTM …

Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease Page 1 Global
Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review D. Rebecca …

Introduction Nontuberculous mycobacterial (NTM) lung disease (LD) is the most common
clinical manifestation of NTM infection and is a growing health concern. Up to 85% of NTM …

A uniform prognostic marker is needed for nontuberculous mycobacterial pulmonary
disease (NTM-PD) due to the diverse clinical course. We aimed to seek the utility of the …

Nontuberculous mycobacteria (NTM) represent an important group of environmentally
saprophytic and potentially pathogenic bacteria that can cause serious mycobacterioses in …

Bronchiectasis is characterized by systemic inflammation and multiple comorbidities. This
study aimed to investigate the clinical outcomes based on the bronchiectasis etiology …

Immunosuppression and host vulnerability play a key role in non-tuberculous mycobacteria
(NTM) pathogenesis. The objective of this study was to compare the clinical characteristics …

Objectives We aimed to evaluate the activity of PBTZ169 and pretomanid against non-
tuberculous mycobacteriosis (NTM) in vitro and in vivo. Methods The minimum inhibitory …

Background Whether antimicrobial treatment improves long-term survival in patients with
Mycobacterium avium complex pulmonary disease (MAC-PD) is unclear. Methods We …

Patients with nontuberculous mycobacterial lung disease (NTM-LD) have increased
mortality. The impact of NTM species on the risk of mortality remains unclear, especially that …